Puma Biotechnology Inc (PBYI) — Free Cash Flow Generation Index
Puma Biotechnology Inc (PBYI) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $14.46 Million represents 1% of operating cash flow ($14.42 Million). See PBYI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Puma Biotechnology Inc Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Puma Biotechnology Inc across 6 annual periods. Explore how well can Puma Biotechnology Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Puma Biotechnology Inc (2019–2025)
Year-by-year Free Cash Flow Generation Index for Puma Biotechnology Inc. For the full company profile including market capitalisation, see Puma Biotechnology Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $41.73 Million | $41.80 Million | $71.00K | ▼ 0.0% |
| 2024 | 1.00x | $38.86 Million | $38.92 Million | $56.00K | ▲ +87.7% |
| 2023 | 0.53x | $14.37 Million | $27.01 Million | $12.64 Million | ▼ -46.8% |
| 2021 | 1.00x | $20.65 Million | $20.65 Million | $1.00K | ▲ +104.2% |
| 2020 | -24.06x | $-19.25 Million | $800.00K | $20.05 Million | ▼ -2539.1% |
| 2019 | 0.99x | $22.07 Million | $22.38 Million | $306.00K | — |